CIPO Patents = 4

Forward Citations = 461

Loading Chart...

5 inventors (with patents filed for the assignee):

Frank S Caruso (7 out of 23 patents)

John W Lyle (3 out of 17 patents)

Gastone P Bello (2 out of 5 patents)

4. Donald A Johnson (2 out of 4 patents)

5. Fredrick L Minn (1 out of 2 patents)

9 patents: Sort by Forward Citations

1. 6187338 - Anticonvulsant containing composition for treating neuropathic pain (2001-02-13),

2. 6054451 - Analgesic composition and method for alleviating pain (2000-04-25),

3. 6043244 - Method and composition for treating migraine (2000-03-28),

4. 6007841 - Analgesic composition and method for treating pain (1999-12-28),

5. 5939425 - Method for treating a migraine (1999-08-17),

6. 5919826 - Method of alleviating pain (1999-07-06),

7. 5891885 - Method for treating migraine (1999-04-06),

8. 5571079 - Wound dressing (1996-11-05),

9. 5505958 - Transdermal drug delivery device and method for its manufacture (1996-04-09),

Company Overview

Algos Pharmaceutical Corporation is a leading biopharmaceutical company that focuses on developing innovative treatments for a variety of diseases. With a strong focus on research and development, Algos Pharma is dedicated to improving patient outcomes and quality of life. Their cutting-edge technology and commitment to excellence set them apart in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#1 in Neptune, NJ

#1,222 in New Jersey

#32,588 in US

Neptune, NJ, United States of America

Algos Pharmaceutical Corporation

Forward Citations = 461

5 inventors:

Frank S Caruso (7 out of 23 patents)

John W Lyle (3 out of 17 patents)

Gastone P Bello (2 out of 5 patents)

4. Donald A Johnson (2 out of 4 patents)

5. Fredrick L Minn (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Algos Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/algos-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]